IN THE NEWS
Nashville Data Company Predicts Areas in Middle Tennessee Most Vulnerable to 2nd Wave
A Nashville-based AI healthcare company predicts a second wave of COVID-19 infections is most-likely in counties near major Tennessee cities. Decode Health creates software for healthcare companies aimed at identifying diseases and creating data analytics. The company has released a map of counties in the state showing where they believe people are most at-risk of being hospitalized and/or dying from COVID-19.
Blue Health Intelligence and Decode Health Team Up to Validate the Accuracy of Predictive Models for Chronic Disease
CHICAGO (March 10, 2020) – Blue Health Intelligence® (BHI®) and Decode Health are showing how a machine learning (ML) engine can be applied to large data sets to more accurately forecast which patients will get chronic diseases. Decode’s analysis used a representative subset of BHI’s National Data Repository, the largest and [read more...]
Data Analytics Holds Promise of Dramatically Improving Outcomes for Patients with Autoimmune Disease.
The movement to embrace predictive analytics, which has been gathering steam over the past several years, will be especially important as hospitals seek to improve their capabilities to forecast, detect and monitor chronic conditions, especially autoimmune diseases. Read the Article
BLOG POSTS
OUR ABSTRACTS
OUR PUBLICATIONS
RECENT PODCASTS
WEBINARS
Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.
